Careray Digital Medical Technology Co.Ltd(688607) board of supervisors
Verification opinions on the list of incentive objects first granted by the restricted stock incentive plan in 2022
All supervisors of Careray Digital Medical Technology Co.Ltd(688607) (hereinafter referred to as “the company”) carefully reviewed the relevant meeting materials of the sixth (Interim) meeting of the second board of supervisors, and after full and comprehensive discussion and analysis, in accordance with the company law, the securities law, the measures for the administration of equity incentive of listed companies and the Listing Rules of shares on the science and Innovation Board of Shanghai Stock Exchange The self regulatory guidelines for listed companies on the Kechuang board No. 4 – disclosure of equity incentive information, the articles of association and other relevant provisions verify the list of incentive objects granted for the first time by the company’s restricted stock incentive plan in 2022 (hereinafter referred to as the “incentive plan”), and the audit opinions are as follows:
1、 The incentive objects granted with restricted shares have the qualifications specified in the company law and the securities law, meet the incentive object conditions specified in the Listing Rules of science and Innovation Board of Shanghai Stock Exchange, and meet the scope of incentive objects specified in the company’s 2022 restricted stock incentive plan (Draft). The subject qualification is legal and effective.
2、 The incentive objects granted with restricted shares include Mr. Jiang Liu (Liu Jianqiang), the actual controller of the company (American nationality), and Mr. Gao Peng. Among them, Mr. Jiang Liu (Liu Jianqiang) is currently the chairman and general manager of the company; Mr. Gao Peng is currently a director and deputy general manager of the company. As the core leaders of the company, the above-mentioned personnel are the core technicians of the company, which have a decisive influence on the operation, management and development strategy of the company.
In addition, the incentive objects granted with restricted shares also include Mr. Gao Zihuan, the son of Mr. Gao Peng, the actual controller of the company, and 8 other foreign incentive objects of the company (including subsidiaries). These personnel groups all work in key positions of the company (including subsidiaries) and play an important role in business management, technology R & D and business development.
Therefore, it is reasonable and necessary for the incentive plan to take the above-mentioned personnel as incentive objects, which is in line with the actual situation and development needs of the company and the relevant provisions of the Listing Rules of shares on the science and Innovation Board of Shanghai Stock Exchange. To sum up, the board of supervisors agreed to the list of incentive objects granted for the first time in the incentive plan and agreed to determine it in 2022
As the first grant date of the incentive plan, February 15 granted a total of 3209000 restricted shares to 99 incentive objects who met the grant conditions, with the grant price of 17.64 yuan / share.
Careray Digital Medical Technology Co.Ltd(688607) board of supervisors February 16, 2022
